Clinical Trials Directory

Trials / Completed

CompletedNCT00867399

A Safety and Tolerability Study of ABT-126 in Elderly

A Multiple Dose Study of Safety, Tolerability and Pharmacokinetics of ABT-126 in Elderly Subjects

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Abbott · Industry
Sex
All
Age
65 Years
Healthy volunteers
Accepted

Summary

The objectives of this study are to assess the safety, tolerability and pharmacokinetics of ABT-126 in elderly subjects.

Conditions

Interventions

TypeNameDescription
DRUGABT-126See arm for details

Timeline

Start date
2009-03-01
Primary completion
2009-05-01
First posted
2009-03-23
Last updated
2010-11-02

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00867399. Inclusion in this directory is not an endorsement.